Megasoft to sell 36.52% stake in Swiss arm Extrovis AG for $15 million

Megasoft has announced the proposed sale of its entire 36.52% holding in Extrovis AG, Switzerland, to Refex Life Sciences for $15 million.

Leave a Reply

Your email address will not be published. Required fields are marked *